Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5730 of 5804
-
New drug M6229 put to the test in healthy people
Knowledge-focused CompletedThis is a Phase I, single-center, randomized, single-blind, placebo-controlled study in healthy subjects assessing the safety, tolerability and pharmacokinetic profile of three different dose levels of M6229 when administered continuously for 120 hours.
Phase: PHASE1 • Sponsor: Matisse Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
MRSA decolonization kit trial stalls after just one patient
Disease control TerminatedStaphylococcus aureus (S. aureus) is a leading cause of healthcare-associated infections worldwide. S. aureus colonizes several body sites, including the nose, throat, and perineum. Colonization by methicillin-resistant S. aureus (MRSA) increases the risk of infection by up to 27…
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug S-740792 tested in healthy volunteers for first time
Knowledge-focused CompletedThis is a 3-part study of S-740792 in healthy adult participants. Part 1 (single-ascending-dose and food effect) will investigate the safety, tolerability, and pharmacokinetics (PK) of S-740792. Part 2 (multiple-ascending-dose and drug-drug interaction) will investigate the safet…
Phase: PHASE1 • Sponsor: Shionogi • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Survey reveals what ICU nurses know about ventilator care
Knowledge-focused CompletedTo assess intensive care unit (ICU) nurses' knowledge regarding initiation of mechanical ventilation and associated nursing procedures in hospitals of a southern in Iraq.
Sponsor: Aqeel Azeez Arrar • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
One hard bike ride could change your balance and brain – study reveals
Knowledge-focused CompletedThe project involves conducting a series of motor, physiological, biochemical, and psychological tests. The series of tests within the experiment will assess the effect of a single aerobic exercise (graded test) on changes in sensory organization and balance performance (based o…
Phase: NA • Sponsor: University School of Physical Education, Krakow, Poland • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Plastic bag trick to warm preterm babies never tested
Disease control TerminatedThe purpose of this study is to determine whether the combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care reduces the incidence of moderate (…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug RPT1G tested in humans for first time
Knowledge-focused CompletedThis is a first-in-human (FIH), randomized, double-blind, placebo-controlled, single and multiple dose study with staggered dose escalations in healthy participants.
Phase: PHASE1 • Sponsor: Remedy Plan, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:22 UTC
-
New antibody drug HB0056 begins first human safety trial
Knowledge-focused Recruiting nowThe aim of this study is to investigate the safety and tolerability of HB0056 in healthy subjects following single-dose.
Phase: PHASE1 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:18 UTC
-
Heart failure drug study pulled before it started
Symptom relief TerminatedThe goal of this randomized double-blind crossover study is to assess whether a morning dose of the extended release torsemide has a better efficacy than the ordinary immediate release torsemide to induce renal sodium excretion after a salty lunch in patients with stable heart fa…
Phase: PHASE2 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New drug CKD-508 tested for safety in healthy people
Knowledge-focused CompletedThis Phase 1, randomized, parallel-group, placebo-controlled, double-blinded study aims to evaluate the safety, PK, and PD of CKD-508 when administered multiple times once daily to healthy participants.
Phase: PHASE1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Prediabetes drug study pulled before it began
Disease control TerminatedThe goal of this clinical trial is to investigate whether metformin improves vascular function in individuals with prediabetes. The main questions it aims to answer are: 1. Does metformin improve large conduit artery endothelial function in individuals with prediabetes? 2. Does …
Phase: PHASE2 • Sponsor: Diana Jalal • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug ZP9830 enters first human safety study
Knowledge-focused Recruiting nowThe primary object in this research study is to investigate the safety and tolerability of ZP9830 in healthy study participants, and in addition, the study will investigate how ZP9830 works in the body (pharmacokinetics, PK and pharmacodynamics, PD) compared to placebo.
Phase: PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Stem cell trial for rare bleeding disorder pulled before it began
Disease control TerminatedThis study is a clinical study initiated by single-arm, single-center, multiple administration researchers. The main purpose of this study is to evaluate the safety and efficacy of mesenchymal stem cells in refractory ITP subjects. The subjects voluntarily signed the informed con…
Phase: NA • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug ABBV-CLS-616 tested for safety in healthy people
Knowledge-focused CompletedThis is a Phase 1, first in human, randomized, four-part study to investigate the safety, tolerability, and pharmacokinetics of ABBV-CLS-616 after oral dosing in healthy volunteers.
Phase: PHASE1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Cricket flour snacks put to the test: do they really curb hunger?
Knowledge-focused CompletedThis randomized, single-blind, triple crossover study investigated the effects of baked snacks containing either cricket flour (Acheta domesticus), pea flour (both at 15%), or a wheat flour-based control. One hundred adult participants were recruited and consumed each of the thre…
Phase: NA • Sponsor: University of Turin, Italy • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New drug LY4005130 tested in healthy people for first time
Knowledge-focused CompletedThe purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in healthy participants. The study drug will be administered either subcutaneously (SC) (under the skin) or intravenously (IV) (into a vein in the arm). Blood tests will be pe…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug PRX019 takes first step: safety check in healthy people
Knowledge-focused CompletedThe purpose of this study is to assess the safety and tolerability of PRX019 in healthy adult participants.
Phase: PHASE1 • Sponsor: Prothena Biosciences Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Simple Eye-Closing trick may sharpen Pre-Surgery measurements
Knowledge-focused Recruiting nowCataract surgery is one of the most common performed surgeries in the world. While in the early beginnings of cataract surgery, visual rehabilitation was the main goal of the procedure, refractive outcome and subsequent relative spectacles independency is gaining increasing impor…
Phase: NA • Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Do emails and texts get people to join gut health research?
Knowledge-focused CompletedThis study is a randomized controlled trial nested in the "Le French Gut" e-cohort aiming to test the efficacy of 4 reminder strategies (emails and/or SMS with standard and/or institutional wording) in increasing participation of inactive volunteers. This trial is led in collabo…
Phase: NA • Sponsor: SKEZI • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New drug ALN-AGT01 RVR tested for safety in healthy people
Knowledge-focused CompletedThe purpose of this study is to evaluate the safety, tolerability and PK of single ascending doses of ALN-AGT01 RVR.
Phase: PHASE1 • Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:50 UTC